The Top 15 Best-Selling Drugs of 2017
Amid Talk of Curbing Prices, Most Treatments Show Sales Gains
Crowdfunding for Science: Models of Best Practice
It’s Not Just the Science That Has to Be Memorable
Gut Microbiome: Both a Friend and a Foe
We Need to Stay on the Gut Microbiome’s Good Side or Risk Microbiota Dysbiosis
Flip the DNA Nanoswitch, Power the Clinical App
A Molecular Interaction Detection Platform Uses a Gel-based Readout
For full access to this article login to GEN Select now.
Managing PTMs in Protein Therapeutics
Ultimate Success of Biosimilars Linked to Adroit Handling of Post-Translational Modifications
- As more and more biopharmaceuticals move along the torturous process of development, clinical evaluation, and approval, dealing with changes to these complex protein molecules becomes increasingly paramount. A number of meetings and symposia have examined this question lately, and it’s clear that the technology is ramping up to successfully ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.